Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST)

Bibliographic Data

ID14907119
AuthorsBruno Spire (0000-0002-3546-8020, Inserm), Gregory M Lucas (0000-0002-3013-4339, Johns Hopkins University), Patrizia Carrieri (0000-0002-6794-4837, Inserm, corresponding author), M Patrizia Carrieri
Year2007
Volume18
Issue4
Pages262-270
Publication date2007-08-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueInternational Journal of Drug Policy (JOURNAL)
Journal identifiersISSN: 0955-3959 • E-ISSN: 1873-4758
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2006.12.014
PMID17689374
OpenAlexW2145585866
LanguageEN
Citations received19
References cited87

Buprenorphine · Expanded access · Family medicine · Methadone · Opiate Substitution Treatment · Opioid · Psychiatry · Psychosocial · HIV Research and Treatment · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Internal Medicine · Oncology

  • Substance Use

    Open Access•Adam Gonzalez, Jennifer Barinas et al.•Current HIV/AIDS Reports•2011

  • Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs

    Open Access•Frederick L Altice, Adeeba Kamarulzaman et al.•The Lancet•2010

  • Drilling Down in Norm Diffusion

    Open Access•Enrique Restoy, Stefan Elbe•Global Studies Quarterly•2021

  • Changes in drug use are associated with health-related quality of life improvements among methadone maintenance patients with HIV/Aids

    Open Access•Bach Xuan Tran, Arto Ohinmaa et al.•Quality of Life Research•2011

  • African American/Black and Latino Adults with Detectable HIV Viral Load Evidence Substantial Risk for Polysubstance Substance Use and Co-occurring Problems

    Open Access•Charles M Cleland, Marya Gwadz et al.•AIDS and Behavior•2021

  • Rapid Implementation of Service Delivery Changes to Mitigate Covid-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program

    Open Access•K Michelle Peavy, James Darnton et al.•AIDS and Behavior•2020

  • Methadone Maintenance Therapy Decreases the Rate of Antiretroviral Therapy Discontinuation Among HIV-Positive Illicit Drug Users

    Open Access•Hudson Reddon, M-J Milloy et al.•AIDS and Behavior•2013

  • Substance Use Predictors of Poor Medication Adherence

    Open Access•Adam Gonzalez, Matthew J Mimiaga et al.•AIDS and Behavior•2012

  • Depressive Symptoms and Antiretroviral Therapy (ART) Initiation Among HIV-Infected Russian Drinkers

    Open Access•Tracie M Goodness, Tibor P Palfai et al.•AIDS and Behavior•2013

  • Trends in Aids Mortality, Retention in Opioid Agonist Therapy, and HIV RNA Suppression in HIV-Infected People Who Injected Drugs from 2000 to 2015

    Open Access•Gabriel Vallecillo, María José Robles et al.•AIDS and Behavior•2018

  • Prescription Opioid Injection Among HIV-Positive People Who Inject Drugs in a Canadian Setting

    Open Access•Stephanie Lake, Thomas Kerr et al.•AIDS and Behavior•2016

  • Determinants of health-related quality of life in adults living with HIV in Vietnam

    Bach Xuan Tran, Arto Ohinmaa et al.•AIDS Care•2011

  • Distributive sharing among HIV–HCV co-infected injecting drug users

    Marie Jauffret-Roustide, Marie Jauffret‐roustide et al.•AIDS Care•2011

  • “We fear the police, and the police fear us”

    Matthew J Mimiaga, Steven A Safren et al.•AIDS Care•2010

  • Drug harms and drug policies in Sub-Saharan Africa

    Open Access•Tammy Rhodes, Reychad Abdool•International Journal of Drug…•2016

  • Universal access to HIV/Aids treatment for injecting drug users

    Open Access•Andrew Ball, Andrew Lee Ball•International Journal of Drug…•2007

  • Harm reduction intensity—Its role in Haart adherence amongst drug users in Amsterdam

    Open Access•Femke A E Lambers, Ineke G Stolte et al.•International Journal of Drug…•2011

  • Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania

    Open Access•Barrot H Lambdin, Jennifer Lorvick et al.•International Journal of Drug…•2017

  • Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs)

    Open Access•Martin C Donoghoe, Annette Verster et al.•International Journal of Drug…•2008

  • Adherence to combination antiretroviral therapies in HIV patients of low health literacy

    Seth C Kalichman, Bineetha Ramachandran et al.•Journal of General Internal…•1999

  • Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection

    Open Access•Joan S Tucker, M Audrey Burnam et al.•The American Journal of Medicine•2003

  • Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

    Open Access•Julia H Arnsten, Penelope Demas et al.•Journal of General Internal…•2002

  • Social Support, Positive States of Mind, and HIV Treatment Adherence in Men and Women Living With HIV/Aids.

    Jeffrey S Gonzalez, Frank J Penedo et al.•Health Psychology•2004

  • Non-adherence to highly active antiretroviral therapy predicts progression to Aids

    David R Bangsberg, Sharon Perry et al.•AIDS•2001

  • Depressive Symptoms, Neurocognitive Impairment, and Adherence to Highly Active Antiretroviral Therapy Among HIV-Infected Persons

    Open Access•Adriana Ammassari, Andrea Antinori et al.•Psychosomatics•2004

  • Factors Affecting Adherence to Antiretroviral Therapy

    Margaret A Chesney•Clinical Infectious Diseases•2000

  • Predictors of Self-Reported Adherence and Plasma HIV Concentrations in Patients on Multidrug Antiretroviral Regimens

    Allen L Gifford, Jill E Bormann et al.•JAIDS Journal of Acquired Immune…•2000

  • Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users

    Barbara J Turner, Christine Laine et al.•Journal of General Internal…•2003

  • Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

    Gregory M Lucas, Kelly A Gebo et al.•AIDS•2002

  • Global overview of injecting drug use and HIV infection among injecting drug users

    Carmen Aceijas, Gerry V Stimson et al.•AIDS•2004

  • Mortality, CD4 Cell Count Decline, and Depressive Symptoms Among HIV-Seropositive Women

    Jeannette R Ickovics, Merle E Hamburger et al.•JAMA•2001

  • Hospitalization for depressive syndrome in a cohort of HIV-infected patients contaminated through injecting drug use

    Catherine Marimoutou, Patrizia Carrieri et al.•AIDS Care•2003

  • Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus

    N Singh, Cheryl Squier et al.•AIDS Care•1996

  • Access to antiretroviral treatment among French HIV infected injection drug users

    Patrizia Carrieri, M P Carrieri et al.•Journal of Epidemiology and…•1999

  • Adherence to HIV combination therapy

    Open Access•Margaret A Chesney, Michel Morin et al.•Social Science & Medicine•2000

  • Adherence to highly active antiretroviral therapies (Haart) in HIV-infected patients

    Open Access•Bruno Spire, Ségolène Duran et al.•Social Science & Medicine•2002

Unique citing works19
Citations per year1
Citation span2007 - 2021 (15)
Citation velocityhistorical
Highly citedNo
Citation typesNeutral: 19

Tools

Open DOISci-Hub
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae